Catalyst Wire Dossier Catalyst Wire Dossier

Ingavirin Forte

· Valenta Pharm JSC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ingavirin Forte, covering 2025-07-08 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers [Phase 1]

See pricing